Electrophysiologic effects of magnesium sulfate infusion in patients with cardiac conduction defects.

References

• Iseri LT, Freed J, Bures AR: Magnesium deficiency and cardiac disorders. Am J Med 58: 837–846, 1975.
   PubMed Web of Science ®Google Scholar
• Chadda K, Ballas M, Bodenheiner MM: Efficacy of magnesium in patients with hypomagnesemia and cardiac arrhythmia (abstract). Circulation 70 (Suppl II):444, 1984.
   Google Scholar
• Iseri LT: Magnesium and cardiac arrhythmias. Magnesium 5: 111–126, 1986.
   PubMedGoogle Scholar
• Seelig M: Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations. Magnesium and chloride loss in refractory potassium repletion. Am J Cardiol 63: 4G–21G, 1989.
   PubMed Web of Science ®Google Scholar
• Keller PK, Aronson RS: The role of magnesium in cardiac arrhythmias. Progr Cardiovasc Dis 32: 433–448, 1990.
   PubMed Web of Science ®Google Scholar
• Keren A, Tzivoni D: Magnesium therapy in ventricular arrhythmias. PACE 13: 937–945, 1990.
   Google Scholar
• Critelli G, Ferro G, Adinolfi L, Perticone F, Maione S, Condorelli M: L'action antiarythmique des cations de magnèsium. Protection de l'excitabilité ventriculaire au cours de la therapie tonicardiaque. Arch Mal Coeur 72: 879–885, 1979.
   PubMedGoogle Scholar
• Specter MJ, Scweizer E, Goldman RH: Studies on magnesium's mechanism of action in digitalis-induced arrhythmias. Circulation 52: 1001–1005, 1975.
   PubMedGoogle Scholar
• Whang R, Oei T, Watanabe A: Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Arch Intern Med 145: 655–656, 1985.
   PubMedGoogle Scholar
• Perticone F, Pintaudi C, Cuda G, Spadea F, Tassone P, Mattioli PL: I sali di magnesio nel trattamento della tachicardia ventricolare. G Ital Cardiol 17: 857–864, 1987.
   PubMedGoogle Scholar
• Seller RH: The role of magnesium in digitalis toxicity. Am Heart J 82: 551–556, 1971.
   PubMedGoogle Scholar
• Cohen L, Kitzes R: Magnesium sulfate and digitalis toxic arrhythmias. JAMA 249: 2808–2810, 1983.
   PubMed Web of Science ®Google Scholar
• Abraham AS, Rosenman D, Meshulam Z, Zion M, Eylath U: Serum, lymphocyte, and erythrocyte potassium, magnesium, and calcium concentrations and their relation to tachyarrhythmias in patients with acute myocardial infarction. Am J Med 81: 983–988, 1986.
   PubMed Web of Science ®Google Scholar
• Bunton RW: Value of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting. Thorax 38: 946–950, 1983.
   PubMedGoogle Scholar
• Perticone F, Borelli D, Ceravolo R, Mattioli PL: Antiarrhythmic short-term protective magnesium treatment in ischemic dilated cardiomyopathy. J Am Coll Nutr 9: 492–499, 1990.
   PubMed Web of Science ®Google Scholar
• Critelli G, Reale A: Magnesium and cardiac arrhythmias. Reappraisal of an old substance. Cardiologia 35 (Suppl I):39- 42, 1990.
   Google Scholar
• Topol EJ, Lerman BB: Hypomagnesemic torsades de pointes. Am J Cardiol 52: 1367–1368, 1983.
   PubMedGoogle Scholar
• Ramee SR, White CJ, Svinarich JT, Watson TD, Fow RF: Torsade de pointes and magnesium deficiency. Am Heart J 109: 164–167, 1985.
   PubMed Web of Science ®Google Scholar
• Perticone F, Adinolfi L, Bonaduce D: Efficacy of magnesium sulfate in the treatment of torsade de pointes. Am Heart J 112: 847–849, 1986.
   PubMed Web of Science ®Google Scholar
• Tzivoni D, Keren A, Cohen AM, Loebel H, Zahavit I, Chensbraun A, Stern S: Magnesium therapy for torsade de pointes. Am J Cardiol 53: 528–530, 1984.
   PubMed Web of Science ®Google Scholar
• Smith PK, Winkler AW, Hoff HE: Electrocardiographic changes and concentration of magnesium in serum following intravenous injection of magnesium salts. Am J Physiol 126: 720–730, 1939.
   Google Scholar
• Surawicz B, Lepeschkin E, Herrlich HC: Low and high magnesium concentrations at various calcium levels: effect on the monophasic action potential, electrocardiogram, and contractility of isolated rabbit hearts. Circ Res 9: 811–818, 1961.
   Google Scholar
• Watanabe Y, Dreifus LS: Electrophysiologic effects of magnesium and its interactions with potassium. Cardiovasc Res 6: 79–88, 1972.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Hiromasa S, Tsuji Y, Katoh T, Watanabe Y: Electrophysiologic and pathophysiologic significance of Mg2+ on conduction and automaticity in the rabbit atrioventricular node (abstract). J Am Coll Cardiol 5: 461, 1985.
   Google Scholar
• Bernstein M, Simkins S: Magnesium: the effects of intravenous injections on the human heart. J Lab Clin Med 25: 131–141, 1939.
   Google Scholar
• Boyd LJ, Scherf D: Magnesium sulfate in paroxysmal tachycardia. Am J Med Sci 206: 43–48, 1943.
   Google Scholar
• Szekely P: The action of magnesium on the heart. Br Heart J 8: 115–124, 1946.
   Google Scholar
• Di Carlo LA, Morady F, De Buitleir M, Krol RB, Schuring L, Annesley TM: Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 7: 1356–1362, 1986.
   PubMedGoogle Scholar
• Kulick DL, Hong R, Ryzen E, Rude KR, Rubin JN, Elkayam U, Rahimtoola SH, Bhandari AK: Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 115: 367–373, 1988.
   PubMed Web of Science ®Google Scholar
• Sager PT, Widerhorn J, Peterson R, Leon C, Ryzen E, Rude R, Rahimtoola SH, Bhandari AK: Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia. Am Heart J 119: 308–316, 1990.
   PubMedGoogle Scholar
• Bazett HC: An analysis of the time-relation of electrocardiogram. Heart 7: 353–369, 1920.
   Google Scholar